{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:46:48Z","timestamp":1792000008463,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020231","name":"Fundaci\u00f3 Catalana de Pneumologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007509","name":"Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica","doi-asserted-by":"publisher","award":["1551-2024"],"award-info":[{"award-number":["1551-2024"]}],"id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04495-6","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:31:06Z","timestamp":1784539866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and internal validation of a nomogram to predict pulmonary hypertension in fibrosing interstitial lung diseases"],"prefix":"10.1186","volume":"26","author":[{"given":"David","family":"Rodr\u00edguez-Plaza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Alfaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"L\u00f3pez-Monzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Bermudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Vicens-Zygmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Hern\u00e1ndez-Argudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Pe\u00f1afiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Del R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salud","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Molina-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"3","key":"4495_CR1","doi-asserted-by":"publisher","first-page":"e12127","DOI":"10.1002\/pul2.12127","volume":"12","author":"SM Nikkho","year":"2022","unstructured":"Nikkho SM, Richter MJ, Shen E, et al. Clinical significance of pulmonary hypertension in interstitial lung disease: a consensus statement from the Pulmonary Vascular Research Institute\u2019s innovative drug development initiative\u2014Group 3 pulmonary hypertension. Pulm Circ. 2022;12(3):e12127.","journal-title":"Pulm Circ"},{"issue":"1","key":"4495_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12931-020-01570-2","volume":"21","author":"G Ruffenach","year":"2020","unstructured":"Ruffenach G, Hong J, Vaillancourt M, et al. Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights. Respir Res. 2020;21(1):303.","journal-title":"Respir Res"},{"issue":"5","key":"4495_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/MCP.0000000000000790","volume":"27","author":"J Behr","year":"2021","unstructured":"Behr J, Nathan SD. Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment. Curr Opin Pulm Med. 2021;27(5):396\u2013404.","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"4495_CR4","doi-asserted-by":"publisher","first-page":"00272","DOI":"10.1183\/23120541.00272-2022","volume":"8","author":"S Dhont","year":"2022","unstructured":"Dhont S, Zwaenepoel B, Vandecasteele E, et al. Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need. ERJ Open Res. 2022;8(4):00272\u20132022.","journal-title":"ERJ Open Res"},{"issue":"9","key":"4495_CR5","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.healun.2017.02.016","volume":"36","author":"H Gall","year":"2017","unstructured":"Gall H, Felix JF, Schneck FK, et al. The giessen pulmonary hypertension registry: survival in pulmonary hypertension subgroups. J Heart Lung Transpl. 2017;36(9):957\u201367.","journal-title":"J Heart Lung Transpl"},{"issue":"2","key":"4495_CR6","doi-asserted-by":"publisher","first-page":"e12405","DOI":"10.1002\/pul2.12405","volume":"14","author":"L Piccari","year":"2024","unstructured":"Piccari L, Kovacs G, Jones S, et al. The European voice of the patient living with pulmonary hypertension associated with interstitial lung disease: diagnosis, symptoms, impacts, and treatments. Pulm Circ. 2024;14(2):e12405.","journal-title":"Pulm Circ"},{"issue":"8","key":"4495_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1159\/000524263","volume":"101","author":"L Piccari","year":"2022","unstructured":"Piccari L, Wort SJ, Meloni F, et al. The effect of borderline pulmonary hypertension on survival in chronic lung disease. Respiration. 2022;101(8):717\u201327.","journal-title":"Respiration"},{"issue":"4","key":"4495_CR8","doi-asserted-by":"publisher","first-page":"2401200","DOI":"10.1183\/13993003.01200-2024","volume":"64","author":"OA Shlobin","year":"2024","unstructured":"Shlobin OA, Adir Y, Barbera JA, et al. Pulmonary hypertension associated with lung diseases. Eur Respir J. 2024;64(4):2401200.","journal-title":"Eur Respir J"},{"issue":"1","key":"4495_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12872-022-02495-y","volume":"22","author":"T Abu","year":"2022","unstructured":"Abu T, Levi A, Hasdai D, et al. Preoperative evaluation of pulmonary hypertension in lung transplant candidates: echocardiography versus right heart catheterization. BMC Cardiovasc Disord. 2022;22(1):53.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"4495_CR10","first-page":"e2021032","volume":"38","author":"MP Huitema","year":"2022","unstructured":"Huitema MP, Post MC, Grutters JC, et al. Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study. Sarcoidosis Vasc Diffuse Lung Dis. 2022;38(4):e2021032.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"12","key":"4495_CR11","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.healun.2025.08.005","volume":"44","author":"A Bosacoma","year":"2025","unstructured":"Bosacoma A, Garcia AR, Lozano JJ, Sidorova J, Tura-Ceide O, Blanco I, et al. Distinct plasma proteome in severe pulmonary hypertension associated with chronic lung disease. J Heart Lung Transpl. 2025;44(12):e133\u201376.","journal-title":"J Heart Lung Transpl"},{"issue":"4","key":"4495_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1056\/NEJMoa2008470","volume":"384","author":"A Waxman","year":"2021","unstructured":"Waxman A, Restrepo-Jaramillo R, Thenappan T, et al. Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease. N Engl J Med. 2021;384(4):325\u201334.","journal-title":"N Engl J Med"},{"issue":"38","key":"4495_CR13","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618\u2013731.","journal-title":"Eur Heart J"},{"issue":"14","key":"4495_CR14","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.3390\/diagnostics13142354","volume":"13","author":"A Kacprzak","year":"2023","unstructured":"Kacprzak A, Tomkowski W, Szturmowicz M. Pulmonary hypertension in the course of interstitial lung diseases\u2014a personalised approach is needed to identify a dominant cause and provide an effective therapy. Diagnostics. 2023;13(14):2354.","journal-title":"Diagnostics"},{"issue":"19","key":"4495_CR15","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3390\/cells12192394","volume":"12","author":"ZA Haynes","year":"2023","unstructured":"Haynes ZA, Chandel A, King CS. Pulmonary hypertension in interstitial lung disease: updates in disease, diagnosis, and therapeutics. Cells. 2023;12(19):2394.","journal-title":"Cells"},{"issue":"9","key":"4495_CR16","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1161\/CIRCRESAHA.121.319970","volume":"130","author":"N Singh","year":"2022","unstructured":"Singh N, Dorfm\u00fcller P, Shlobin OA, et al. Group 3 pulmonary hypertension: from bench to bedside. Circ Res. 2022;130(9):1404\u201322.","journal-title":"Circ Res"},{"issue":"2","key":"4495_CR17","doi-asserted-by":"publisher","first-page":"e12213","DOI":"10.1002\/pul2.12213","volume":"13","author":"L Piccari","year":"2023","unstructured":"Piccari L, Allwood B, Antoniou K, et al. Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: a consensus statement from the Pulmonary Vascular Research Institute\u2019s Innovative Drug Development Initiative - Group 3 Pulmonary Hypertension. Pulm Circ. 2023;13(2):e12213.","journal-title":"Pulm Circ"},{"issue":"4","key":"4495_CR18","doi-asserted-by":"publisher","first-page":"e12141","DOI":"10.1002\/pul2.12141","volume":"12","author":"R Parikh","year":"2022","unstructured":"Parikh R, Konstantinidis I, O\u2019Sullivan DM, et al. Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection. Pulm Circ. 2022;12(4):e12141.","journal-title":"Pulm Circ"},{"issue":"3","key":"4495_CR19","doi-asserted-by":"publisher","first-page":"e12273","DOI":"10.1002\/pul2.12273","volume":"13","author":"R Parikh","year":"2023","unstructured":"Parikh R, O\u2019Sullivan DM, Farber HW. The PH-ILD Detection tool: external validation and use in patients with ILD. Pulm Circ. 2023;13(3):e12273.","journal-title":"Pulm Circ"},{"issue":"4","key":"4495_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.healun.2023.11.005","volume":"43","author":"SD Nathan","year":"2024","unstructured":"Nathan SD, Chandel A, Wang Y, et al. Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: evolution of the model FORD. J Heart Lung Transpl. 2024;43(4):547\u201353.","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"4495_CR21","doi-asserted-by":"publisher","first-page":"e12197","DOI":"10.1002\/pul2.12197","volume":"13","author":"P Joseph","year":"2023","unstructured":"Joseph P, Savarimuthu S, Zhao J, et al. Noninvasive determinants of pulmonary hypertension in interstitial lung disease. Pulm Circ. 2023;13(1):e12197.","journal-title":"Pulm Circ"},{"issue":"9","key":"4495_CR22","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"4495_CR23","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1164\/ajrccm.158.5.9710086","volume":"158","author":"PL Enright","year":"1998","unstructured":"Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158(5):1384\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"4495_CR24","first-page":"72","volume":"14","author":"S Karazincir","year":"2008","unstructured":"Karazincir S, Balc\u0131 A, Seyfeli E, et al. CT assessment of main pulmonary artery diameter. Diagn Interv Radiol. 2008;14(2):72\u20134.","journal-title":"Diagn Interv Radiol"},{"issue":"5","key":"4495_CR25","doi-asserted-by":"publisher","first-page":"e0126646","DOI":"10.1371\/journal.pone.0126646","volume":"10","author":"SH Lee","year":"2015","unstructured":"Lee SH, Kim YJ, Lee HJ, et al. Comparison of CT-determined pulmonary artery diameter, aortic diameter, and their ratio in healthy and diverse clinical conditions. PLoS ONE. 2015;10(5):e0126646.","journal-title":"PLoS ONE"},{"key":"4495_CR26","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Moons KGM, Dhiman P, et al. TRIPOD\u2009+\u2009AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378.","journal-title":"BMJ"},{"issue":"10","key":"4495_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.arbres.2025.03.015","volume":"61","author":"DA Rodr\u00edguez-Chiarad\u00eda","year":"2025","unstructured":"Rodr\u00edguez-Chiarad\u00eda DA, Torres-Castro R, Piccari L, et al. A systematic review and expert recommendation on the diagnosis of pulmonary hypertension associated with lung disease: a position paper of the Spanish society of pulmonology and thoracic surgery (SEPAR). Arch Bronconeumol. 2025;61(10):617\u201325.","journal-title":"Arch Bronconeumol"},{"issue":"1","key":"4495_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.chest.2022.02.012","volume":"162","author":"FF Rahaghi","year":"2022","unstructured":"Rahaghi FF, Kolaitis NA, Adegunsoye A, et al. Screening strategies for pulmonary hypertension in patients with interstitial lung disease: a multidisciplinary delphi study. Chest. 2022;162(1):145\u201355.","journal-title":"Chest"},{"issue":"5","key":"4495_CR29","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1007\/s12325-026-03508-4","volume":"43","author":"D Zisman","year":"2026","unstructured":"Zisman D, Sahay S, Bandyopadhyay D, et al. Screening for pulmonary hypertension in interstitial lung disease: preliminary results from the PHINDER study. Adv Ther. 2026;43(5):2071\u201389.","journal-title":"Adv Ther"},{"issue":"1","key":"4495_CR30","doi-asserted-by":"publisher","first-page":"2004455","DOI":"10.1183\/13993003.04455-2020","volume":"57","author":"M Remy-Jardin","year":"2021","unstructured":"Remy-Jardin M, Ryerson CJ, Schiebler ML, et al. Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society. Eur Respir J. 2021;57(1):2004455.","journal-title":"Eur Respir J"},{"issue":"1","key":"4495_CR31","doi-asserted-by":"publisher","first-page":"1701311","DOI":"10.1183\/13993003.01311-2017","volume":"51","author":"T Furukawa","year":"2018","unstructured":"Furukawa T, Kondoh Y, Taniguchi H, et al. A scoring system to predict the elevation of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis. Eur Respir J. 2018;51(1):1701311.","journal-title":"Eur Respir J"},{"issue":"165","key":"4495_CR32","doi-asserted-by":"publisher","first-page":"210220","DOI":"10.1183\/16000617.0220-2021","volume":"31","author":"AB Waxman","year":"2022","unstructured":"Waxman AB, Elia D, Adir Y, et al. Recent advances in the management of pulmonary hypertension with interstitial lung disease. Eur Respir Rev. 2022;31(165):210220.","journal-title":"Eur Respir Rev"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04495-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04495-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04495-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:02:15Z","timestamp":1791997335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04495-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4495"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04495-6","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"2 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Bellvitge University Hospital (approval number: PR219\/24). The requirement for informed consent was waived due to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"David Rodr\u00edguez-Plaza reports personal fees and travel support from Johnson & Johnson and Ferrer. Jesus Ribas reports consulting fees and personal fees from MSD and travel support from Janssen, MSD and Ferrer. Isabel Alfaya reports travel support from Boehringer Ingelheim. Salud Santos reports personal fees from AstraZeneca, GSK, MSD, Chiesi, Menarini, Sanofi and Amb\u00fa. Mar\u00eda Molina-Molina reports grants from Boehringer Ingelheim and Insmed, consulting fees from Boehringer Ingelheim, Ferrer and AstraZeneca, personal fees from Savara, Menarini and Ferrer, and travel support from Boehringer Ingelheim. Sonia L\u00f3pez-Monzoni, Guadalupe Bermudo, Vanesa Vicens-Zygmunt, Yolanda Ruiz, Marta Hern\u00e1ndez-Argudo, Judith Pe\u00f1afiel, Bel\u00e9n Del R\u00edo, \u00c1ngela D\u00edaz and Lara Fuentes declare no conflicts of interest. All declared relationships are outside the submitted work.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"475"}}